Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Short-term Investments (2018 - 2025)

Historic Short-term Investments for Regen BioPharma (RGBP) over the last 4 years, with Q1 2025 value amounting to $17733.0.

  • Regen BioPharma's Short-term Investments changed N/A to $17733.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $17733.0, marking a year-over-year change of. This contributed to the annual value of $17733.0 for FY2024, which is 9203.3% down from last year.
  • According to the latest figures from Q1 2025, Regen BioPharma's Short-term Investments is $17733.0.
  • Regen BioPharma's 5-year Short-term Investments high stood at $222580.0 for Q3 2023, and its period low was $17733.0 during Q3 2024.
  • Its 3-year average for Short-term Investments is $68944.8, with a median of $17733.0 in 2024.
  • Examining YoY changes over the last 5 years, Regen BioPharma's Short-term Investments showed a top increase of 9203.3% in 2024 and a maximum decrease of 9203.3% in 2024.
  • Quarter analysis of 3 years shows Regen BioPharma's Short-term Investments stood at $222580.0 in 2023, then plummeted by 92.03% to $17733.0 in 2024, then changed by 0.0% to $17733.0 in 2025.
  • Its Short-term Investments was $17733.0 in Q1 2025, compared to $17733.0 in Q4 2024 and $17733.0 in Q3 2024.